Aflac Incorporated (AFL) Stock Price: $115.61+0.37 (+0.32%)
The total return cagr for Aflac Incorporated (AFL) stock is 15.21% over the past 12 months. The 3 year average growth rate is 21.36% and the 5 year cagr is 18.01%. Total return includes dividends reinvested.
The closing share price for Aflac Incorporated (AFL) stock was $115.61 for Tuesday, June 9, 2026, up +0.32% from the previous day.
AFL Price Chart
AFL Key Metrics
See All MetricsAFL Earnings Preview
Next Earnings Date
Aug 6, 2026
58 days away
EPS Estimate
1.77
Revenue Est.
$4.10B
Last Quarter Results
EPS
$1.75
vs Estimate
$1.80
Revenue
$4.35B
vs Estimate
$4.20B
AFL Analyst Ratings
Consensus Rating
Based on 14 analysts
Average Price Target
$112.43
-2.8% downside
Low
$99.00
Current
$115.61
High
$130.00
AFL Analyst Estimates
Earnings Per Share (EPS) Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2028 | N/A | $1.99 | N/A | 4 |
| Q2 2028 | N/A | $2.03 | N/A | 6 |
| Q3 2028 | N/A | $2.06 | N/A | 4 |
| Q4 2028 | N/A | $1.99 | N/A | 7 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | N/A | $7.06 | N/A | 9 |
| FY 2027 | N/A | $7.60 | N/A | 9 |
Revenue Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2028 | N/A | $4.09B | N/A | 4 |
| Q2 2028 | N/A | $4.11B | N/A | 6 |
| Q3 2028 | N/A | $4.13B | N/A | 4 |
| Q4 2028 | N/A | $4.13B | N/A | 7 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | N/A | $16.79B | N/A | 9 |
| FY 2027 | N/A | $16.91B | N/A | 9 |
Source: FMP Analyst Consensus Estimates. Forward P/E calculated using average EPS estimate for the nearest fiscal year.
AFL Competitors' Key Metrics
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| 1AFL | $58.84B | $115.61 | +0.32% | +15.21% | +18.01% | +15.39% |
AFL Charts
Valuation Charts
Performance Charts
CAGR Charts
Financial Statement Charts
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- Capital Expenditure
- Acquisitions
- Share Buybacks
- Stock-Based Compensation
- Total Assets
- Total Equity
- Cash & Equivalents
- Accounts Receivable
- Inventory
- PP&E
- Goodwill
- Accounts Payable
- Retained Earnings
- Total Debt
- Long-Term Debt
- Short-Term Debt
About Aflac Incorporated
Aflac Incorporated, operating through its various subsidiary companies, focuses on delivering supplementary health and life insurance policies. The firm's business activities are structured into two primary divisions: Aflac Japan and Aflac U.S. In Japan, the company offers a diverse range of insurance products, including coverage for cancer, medical expenses, income support for nursing care, and the distinct GIFT plan. This segment also provides traditional whole and term life insurance, along with savings-oriented plans like WAYS and child endowment products. Meanwhile, the Aflac U.S. division caters to the American market, furnishing policies that address cancer, accidents, short-term disability, critical illness, and hospital stays. Additionally, it provides dental, vision, long-term care, disability, and both term and whole life insurance options. Aflac distributes its comprehensive suite of products through multiple channels, which include dedicated sales associates, independent brokers, various corporate and individual agencies, and affiliated agencies. Established in 1955, the company maintains its corporate headquarters in Columbus, Georgia.
- Sector
- Financial Services
- Industry
- Insurance - Life
- CEO
- Daniel Paul Amos